Hosted on MSN10m
Sterotherapeutics begins Phase II trial for ST-002 targeting Cushing’s Syndrome
US-based clinical-stage company Sterotherapeutics has announced the commencement of a Phase II clinical trial for its drug ...
Hosted on MSN13m
Is Colonoscopy Still the Gold Standard for Colon Cancer Screening?
Fact checked by Nick Blackmer Most people should get screened for colorectal cancer starting at age 45. Cells in the large ...
WJCL26m
FDA delays when a final rule on what foods can be labeled as ‘healthy’ goes into effect
The FDA's new standards for foods before they can be labeled as "healthy" on their packaging will go into effect about two ...
Altoona Mirror40m
FDA aims to reinstate fired staffers
Barely a week after mass firings at the Food and Drug Administration, some probationary staffers received unexpected news over the weekend: The government wants them back. Beginning Friday night, FDA ...
manilatimes52m
Supernus Announces Fourth Quarter and Full Year 2024 Financial Results
Fourth quarter 2024 net sales of GOCOVRI ® increased 15% to $36.9 million, compared to the same period in 2023. Full year net sales of GOCOVRI increased 9% to $130.8 million, compared to full year ...
manilatimes52m
Arcutis Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
The Company submitted an sNDA for ZORYVE foam for scalp and body psoriasis to the FDA based on the positive results from the pivotal ARRECTOR Phase 3 trial and a Phase 2b trial, which was accepted by ...